Advances in PAD: Evaluating Emerging Evidence

The goal of this activity is to inform participants about the latest clinical data regarding factor Xa inhibitor therapy in patients with peripheral artery disease (PAD) and to improve the use of antithrombotic therapy in patients with PAD who have undergone recent peripheral revascularization.
Educational Partner: Medscape, LLC
Medium: Online Presentation
Commercial Support: Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC

Target Audience

This activity is intended for cardiologists, primary care physicians, and surgeons.

Learning Objectives

Upon completion of this activity, participants will:
  • Have increased knowledge regarding the
    • emerging clinical data for direct oral anticoagulants (DOACs) in the setting of peripheral artery disease (PAD)
  • Have greater competence related to
    • implementation of effective strategies to integrate data into clinical care for patients with PAD
Additional information
ABMS Core Competencies: 
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
CME Coordinator Contact Email: 
Postcard505.65 KB
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Activity opens: 
Activity expires: 
Manesh R. Patel, MD
Professor of Medicine
Duke University Medical Center
Durham, North Carolina
Marc P Bonaca, MD
Associate Professor of Medicine
Director Vascular Research
University of Colorado School of Medicine
Executive Director; CPC Clinical Research
Aurora, Colorado
William R. Hiatt
Professor of Medicine/Cardiology
University of Colorado School of Medicine
Chief Science Officer, CPC Clinical Research
Aurora, Colorado
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Accreditation Statements
Developed through a collaboration between the University of Chicago Medicine and Medscape Education.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Registration: To view this activity, you will need to visit Medscape's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
Please login or create an account to proceed.